Trial intelligence / Profile preview

Testosterone Sample Generation for Anti-doping

NCT04207684Phase 1Completed

Sponsor
Parc de Salut Mar
Start
Feb 2020
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of testosterone cypionate, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of testosterone. Started Feb 2020; status: completed.

02

Drugs

testosterone cypionate

Beyond the preview

Go deeper on NCT04207684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04207684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call